239000002122 magnetic nanoparticles Substances 0.000 claims description 44.
229930003347 taxol Natural products 0.000 claims description 52.239000000546 pharmaceutic aids Substances 0.000 claims abstract description 5.239000003937 drug carriers Substances 0.000 claims abstract description 5.239000003085 diluting agents Substances 0.000 claims abstract description 6.239000008194 pharmaceutical compositions Substances 0.000 claims abstract description 20.230000027455 binding Effects 0.000 claims abstract description 38.108090000623 proteins and genes Proteins 0.000 claims abstract description 48.102000004169 proteins and genes Human genes 0.000 claims abstract description 48.239000000203 mixture Substances 0.000 title claims description 92.201000011510 cancer Diseases 0.000 title claims abstract description 109.108090001123 antibodies Proteins 0.000 title claims abstract description 188.102000004965 antibodies Human genes 0.000 title claims abstract description 188.
Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Priority to US201562147800P priority Critical Priority to US62/147,800 priority Application filed by University Of Tennessee Research Foundation filed Critical University Of Tennessee Research Foundation Publication of WO2016168607A1 publication Critical patent/WO2016168607A1/en Links Inventor Subhash Chauhan Meena Jaggi Satoshi Nagata Tomoko Ise Original Assignee University Of Tennessee Research Foundation Priority date (The priority date is an assumption and is not a legal conclusion. Google Patents WO2016168607A1 - Compositions and methods of muc13 antibodies for cancer treatment and diagnosis WO2016168607A1 - Compositions and methods of muc13 antibodies for cancer treatment and diagnosis
0 kommentar(er)
